- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease, +15 more
- Locations
-
- Fondazione EMN Italy Onlus Torino, Italy
Clinical trial condition
Neoplasms, Plasma Cell
Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.
2,604 public trials
547 recruiting studies
Neoplasms, Plasma Cell trial results
NCT00551928
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Division of Hematology, AOU Città della Salute e della Scienza di Torino Torino, Italy
Completed
Panobinostat/Bortezomib/Dexamethasone in Relapsed or Relapsed-and-refractory Multiple Myeloma
NCT02654990
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Novartis Investigative Site Fayetteville, Arkansas, United States
- Novartis Investigative Site Los Angeles, California, United States
- Novartis Investigative Site Fort Collins, Colorado, United States
- Novartis Investigative Site Gainesville, Florida, United States
NCT04659798
- Conditions
- Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +17 more
- Locations
-
- H. Puerta del Mar Cadiz, Andalusia, Spain
- Hospital Regional Universitario de Malaga (Carlos de Haya) Málaga, Andalusia, Spain
- H. Universitari Son Espases Palma de Mallorca, Balearic Islands, Spain
- H. Universitario de Araba Vitoria-Gasteiz, Basque Country, Spain
NCT04434469
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Concord Repatriation General Hospital Concord, New South Wales, Australia
- LIVERPOOL HOSPITAL; HAEMATOLOGY; Ingham Institute for Medical Research Liverpool, New South Wales, Australia
- Royal Adelaide Hospital; Haematology Clinical Trials Adelaide, South Australia, Australia
- St. Vincent's Hospital Melbourne Fitzroy, South Australia, Australia
NCT03952091
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Capital Medical University (CMU) - Beijing Chao-Yang Hospital Beijing, Beijing Municipality, China
- Peking University Third Hospital Beijing, Beijing Municipality, China
- Capital Medical University (CMU) - Beijing Chao-Yang Hospital Beijing, Beijing Municipality, China
- The First Affiliated Hospital of Bengbu Medical college Bengbu, China
NCT03439293
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Pacific Cancer Medical Center Anaheim, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- SCRI - Florida Cancer Specialists - Panhandle Tallahassee, Florida, United States
- Research Medical Center - Kansas City Kansas City, Missouri, United States
NCT05679258
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Beijing Hospital Beijing, Beijing Municipality, China
- Sir Run Run Hospital, Nanjing Medical University Nanjing, Jiangsu, China
NCT04379817
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Jules Bordet Institute Brussels, Belgium
Completed
Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients
NCT03194867
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- University of Colorado-Site Number:8400001 Denver, Colorado, United States
- University of Kansas Medical Center-Site Number:8400003 Kansas City, Kansas, United States
- Memorial Sloan-Kettering Cancer Center-Site Number:8400002 New York, United States
- Fox Chase Cancer Center-Site Number:8400004 Philadelphia, Pennsylvania, United States